Mutations in either of two genes, LIS1 or DCX (encoding double cortin), account for the majority of classical lissencephaly 1-3 . Consistent with a major role for this protein in neuronal migration, mice with decreased Lis1 expression show disorganization of the cor tical layers, hippocampus and olfactory bulb that occurs in a dose dependent fashion, and they are a model for the human disorder 4 . LIS1 was first identified as a subunit of the brain plateletactivating factor acetylhydrolase 5 , but extensive studies in a variety of model organisms from bread molds to mammals led to the conclusion that LIS1 is essential for the proper regulation and localization of cyto plasmic dynein [6] [7] [8] . Many studies have further delineated the role of LIS1 in neuronal morphogenesis and the maintenance of cell integrity. However, no studies have addressed potential therapeutic approaches for lissencephaly, a devastating human disorder.
a r t i c l e s
Mutations in either of two genes, LIS1 or DCX (encoding double cortin), account for the majority of classical lissencephaly [1] [2] [3] . Consistent with a major role for this protein in neuronal migration, mice with decreased Lis1 expression show disorganization of the cor tical layers, hippocampus and olfactory bulb that occurs in a dose dependent fashion, and they are a model for the human disorder 4 . LIS1 was first identified as a subunit of the brain plateletactivating factor acetylhydrolase 5 , but extensive studies in a variety of model organisms from bread molds to mammals led to the conclusion that LIS1 is essential for the proper regulation and localization of cyto plasmic dynein [6] [7] [8] . Many studies have further delineated the role of LIS1 in neuronal morphogenesis and the maintenance of cell integrity. However, no studies have addressed potential therapeutic approaches for lissencephaly, a devastating human disorder.
We previously showed that LIS1 is required for anterograde trans port of cytoplasmic dynein in a kinesindependent fashion 8 . We found that a substantial fraction of LIS1 is degraded at the periphery (cortex) of the cell 8 . We probed for molecules that were involved in LIS1 degradation using inhibitors and found that calpain inhibitors efficiently prevented the degradation of LIS1, suggesting that LIS1 is degraded by calpaindependent proteolysis 8 . Here we report that inhibition of calpain rescues various phenotypes observed in cell culture and in vivo in Lis1deficient mice that are a model of this disorder. Our work provides a proof of principle for the treat ment of lissencephaly caused by haploinsufficiency of LIS1 and also suggests a new therapeutic strategy for diseases associated with haploinsufficiency.
RESULTS

Calpain inhibitors rescue aberrations in Lis1 +/− MEF cells
First, we examined the response of LIS1 protein abundance to the inhibition of calpain by ALLN in mouse embryonic fibroblast (MEF) cells 4 . LIS1 protein amounts gradually increased in Lis1 +/− MEF cells and reached a plateau 2 h after the start of ALLN treatment (data not shown). After 2 h of administration of ALLN, LIS1 protein abundance increased from 0.5 arbitrary units (AU; where 1.0 AU is equivalent to wildtype levels of LIS1) to 1.1 AU ( Supplementary  Fig. 1 and Fig. 1a) . We also examined the effect of E64d, another Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly a r t i c l e s calpain inhibitor, and obtained similar results ( Fig. 1a: from 0.5 AU to 0.9 AU). The amount of cytoplasmic dynein intermediate chain1 (DIC1) was also increased, suggesting that the protein stability of cytoplasmic dynein was reduced in the Lis1 mutated cells (Fig. 1a) , which could be attributed to the ability of LIS1 either to directly pre vent the degradation of cytoplasmic dynein or to indirectly stabilize cytoplasmic dynein through normalization of its distribution. We also obtained similar results in Lis1 +/− dorsal root ganglia (DRG) with ALLN (LIS1: from 0.4 AU to 0.7 AU, DIC1: 0.8 AU to 1.6 AU) and with E64d (LIS1: from 0.4 AU to 0.9 AU, DIC1: 0.8 AU to 1.5 AU) (Fig. 1b,c) . In contrast, there was no significant effect of calpain inhibitors on LIS1 or DIC1 in Lis1 +/+ MEF cells or DRG neurons (Supplementary Fig. 2a,b) .
We next determined whether preventing the degradation of LIS1 would rescue the aberrant distribution of LIS1 and cyto plasmic dynein within Lis1 +/− MEF cells. Treatment of these cells with ALLN or E64d for 2 h clearly ameliorated the reduction of centrosomal concentration of LIS1 (Supplementary Fig. 2c ). In addition, the abnormal accumulation of cytoplasmic dynein around the centrosome was reversed by ALLN or E64d treatment (Supplementary Fig. 2d ). We also observed these improvements in Lis1 +/− DRG neurons ( Supplementary Fig. 2e,f) , whereas there was no significant effect in Lis1 +/+ DRG neurons ( Supplementary  Fig. 2e,f) . We next addressed whether ALLN or E64d was able to rescue the aberrant distribution of cell components transported by cytoplasmic dynein in Lis1 +/− MEF cells. Mitochondria showed dispersed distribution in Lis1 +/+ MEF cells. By contrast, they clus tered in the perinuclear region of Lis1 +/− MEF cells ( Supplementary  Fig. 2g ). This aberrant clustering was rescued by ALLN or E64d treat ment (Supplementary Fig. 2g ). Immunofluorescence showed that βCOP-positive vesicles had a predominantly juxtanuclear staining pattern in Lis1 +/+ MEF cells (Supplementary Fig. 2h ). In Lis1 +/− MEF cells, this juxtanuclear clustering was disrupted, and βCOP showed punctuate clustering 9 (Supplementary Fig. 2h ). This aberrant distribution of βCOP-positive vesicles in Lis1 +/− MEF cells was also rescued by ALLN or E64d treatment (Supplementary Fig. 2h ). These effects of calpain inhibitors were not observed in Lis1 +/+ MEF cells (Supplementary Fig. 2i-l) . These observations suggest that inhibition of calpains improves the functional defects of cytoplasmic dynein in Lis1 +/− MEF cells.
Calpain inhibitors rescue migration of Lis1 +/− neurons
To determine the effect of calpain inhibitors on mammalian neu ronal migration, we used mouse cerebellar granule neurons in an in vitro migration assay combined with ALLN or E64d treatment [9] [10] [11] [12] . As heterozygous loss of LIS1 leads to lissencephaly in humans, graded decreases in Lis1 abundance results in increased severity of migration defects in mice 4 . We first examined whether inhibition of calpain might affect neuronal migration in wildtype cells and found that calpain inhibition slightly facilitated neuronal migration (Fig. 2a-c) . We next confirmed that Lis1 +/− cerebellar granule neurons have a leftward shift of the bin distribution of migration distance, and the mean distance decreased by approximately half from that of wild type neurons (Fig. 2a-c) . We then tested whether ALLN or E64d treatment was sufficient to rescue the migration defect in Lis1 +/− cerebellar granule neurons. Lis1 +/− cerebellar granule neurons in the presence of ALLN or E64d showed a shift in migration distance bins back toward the right, with a similar distribution to that of wildtype neurons (Fig. 2a,b) . Quantification of mean migration distance of cerebellar granule neurons showed rescue of defective migration in Lis1 +/− cerebellar granule neurons by ALLN or E64d treatment (Fig. 2c) . Specifically, inhibition of LIS1 degradation by ALLN or E64d restored migration to 83.1% (ALLN) or 84.4% (E64d) of wildtype levels. Calpain inhibitors also slightly but sub stantially facilitated neuronal migration in wildtype cells 11 . It was previously shown that overexpression of LIS1 facilitates neuronal migration 11 , so it is possible that calpain inhibition stabilizes LIS1 locally and/or functions by other mechanisms, including modu lation of focal adhesion kinase (FAK), cyclindependent kinase5 (Cdk5) or p35.
FAK, a tyrosine kinase localized to focal adhesions, has been shown to be essential for cell migration 13, 14 . FAK abundance is regulated by calpaindependent cleavage [15] [16] [17] [18] [19] . FAK is also a physiological substrate of Cdk5 during neocortical development [20] [21] [22] . We, therefore, exam ined whether inhibition of calpain might affect components of the focal adhesion complex in granular neurons, but we did not observe obvious differences in the distribution or expression of FAK and vin culin after calpain inhibition ( Supplementary Fig. 3a-e) . Although we cannot completely exclude the possibility that inhibition of calpain modifies signal transduction from focal adhesion, our findings do not support this possibility. 
a r t i c l e s
Calpain knockdown rescues aberrations in Lis1 +/− MEF cells ALLN and E64d are broad cysteine protease inhibitors and can inhibit cysteine proteases other than calpain, including cathepsins and papain 23, 24 . To address whether calpain is responsible for the deg radation of LIS1 protein, we investigated the effect of small interfer ing RNA (siRNA) against calpain. The ubiquitous calpains, µcalpain (calpain1) and mcalpain (calpain2), are heterodimers consisting of large catalytic subunits encoded by the Capn1 and Capn2 genes, respectively, and the small regulatory subunit encoded by Capns1 23, 24 .
Inactivation of µcalpain and mcalpain simultaneously by siRNA was technically challenging. Therefore, we knocked down Capns1 by siRNA, resulting in depletion of both µcalpain and mcalpain 25 ( Supplementary Fig. 4a,b) . After transfection of siRNA targeting Capns1, µcalpain and mcalpain expression gradually decreased over 48 h and was almost undetectable after 96 h ( Supplementary  Fig. 4a,b ). This decrease in calpain expression was associated with an increase of LIS1 and DIC1 abundance in Lis1 +/− MEFs ( Fig. 3) , consistent with the effects of calpain inhibitors discussed above ( Fig. 1 and Supplementary Fig. 1 ). The subcellular distribution abnormalities of LIS1 and DIC1 found in Lis1 +/− cells were rescued by depletion of µcalpain and mcalpain ( Supplementary Fig. 4c,d ).
The aberrant distributions of βCOP and mitochondria were also rescued by depletion of µcalpain and mcalpain ( Supplementary  Fig. 4e ,f). These observations suggest that LIS1 is specifically degraded by calpain, and that selective inhibition of calpain is sufficient to increase LIS1 levels and improve cellular phenotypes.
ALLN partially rescues aberrations in Lis1 +/− mice
These observations of rescue effects prompted us to examine whether administration of ALLN to pregnant Lis1 +/− dams would restore defective neuronal migration in vivo 4 . We first examined the effect of LIS1 protection from degradation by intraperitoneal injection of ALLN. We injected ALLN (38.3 µg per g body weight) into pregnant Lis1 +/− dams at embryonic day 12.5 (E12.5), and examined LIS1 in embryonic brains by western blotting at various times after injection. We found that LIS1 expression increased starting at 1 h after injec tion and reached a plateau 6-12 h later ( Supplementary Fig. 5a ). Expression of LIS1 decreased thereafter and returned to the original level after 24 h (Supplementary Fig. 5a ), suggesting that ALLN is relatively short acting. We therefore performed intraperitoneal injec tion of pregnant dams each day between E9.5 and E17.5 and assessed cell survival and neuronal migration in the brains of in utero-treated offspring. We previously reported a mild reduction of the density of cells in the neocortex of the Lis1 +/− mice due to apoptotic cell death in the ventricular zone 9 . Lis1 +/− mice showed a reduction of brain weight compared to wildtype control pups, an effect that was partially res cued by administration of ALLN (Fig. 4a) . In Lis1 +/− mice, apoptotic cell death was increased at E15.5 (ref. 9), whereas it was clearly sup pressed by administration of ALLN (Fig. 4b) . LIS1 is essential for neuroepithelial stem cell proliferation 4, 26 . To trace the proliferation of stem cells, we performed BrdU pulse labeling of E13.5 embyros and found that BrdU incorporation was not significantly different among the four groups (Supplementary Fig. 5b ). Although calpain inhibitors a r t i c l e s might facilitate proliferation of neuroepithelial stem cells in Lis1 +/− mice, the effects on heterozygotes may be too small to measure. Thus, we believe that suppression of apoptotic cell death is more likely to contribute to the rescue of brain size by ALLN than enhancement of neuroepithelial stem cell proliferation. We next examined the effects of ALLN on the cortical and hippocampal layering of neurons. Lis1 +/− mice showed laminar splitting and discontinuities of pyramidal cells in the CA3 and CA2 regions 4 of the hippocampus (Fig. 4c) . After administration of ALLN in utero, Lis1 +/− mice also showed splitting and diffuse packing of pyramidal cells, but these defects were markedly improved ( Fig. 4c  and Supplementary Fig. 5c ). To examine cortical lamination, we used brainspecific homeobox protein1 (Brn1) immunoreactivity to label interneurons of layers 2 and 3 (ref. 27 ). In Lis1 +/− mice, Brn1-positive cells showed a broader distribution compared to Lis1 +/+ mice (Fig. 4d) . Administration of ALLN resulted in a more tightly packed lamination in Lis1 +/− mice (Fig. 4d) . To confirm the morphological improvement by daily ALLN treatment in utero, we performed quantitative BrdU birthdating analysis. In Lis1 +/− mice, the distribution of labeled cells was shifted downward toward the ventricular zone in the cortex, and BrdUlabeling was more dif fusely localized 4 (Fig. 4e) . The migration defects associated with the disruption of Lis1 were partially rescued by ALLN treatment (Fig. 4e) . In a migration assay using granular neurons in vitro, calpain inhibitors slightly but significantly facilitated migration of wildtype neurons (Fig. 2) , whereas in utero treament with a calpain inhibitor did not have a significant effect on wildtype a r t i c l e s embryos (Fig. 4e) . We examined neuronal migration in vivo in the embryo 13-15 d after the start of injection of a calpain inhibitor, whereas we performed the in vitro migration assay of granular neurons 16 h after treatment with calpain inhibitors. Over several days of migration in vivo, slight differences in the speed of neu ronal migration may not result in a detectable phenotypic differ ence, as once the migrating neurons reach their proper positions in the brain, they receive stop signals for migration 28 . Examination of neuronal migration in vivo in the embryo may not be sensi tive enough for the detection of this statistically significant but small difference (73.9 µm/69.4 µm: 6.5% ± 1.8%, s.e.m.; Fig. 2c ).
In contrast, in Lis1heterozygous granular neurons, the difference in migration distance between the absence and presence of ALLN was significant (57.7 µm/37.4 µm: 54.3% ± 4.2%, s.e.m.; Fig. 2c) .
To examine the effect of calpain knockdown on neuronal migra tion in vivo, we introduced a short hairpin RNA (shRNA) targeting Capns1 into the E14 mouse neocortex by in utero electropora tion. This shRNA depleted the neocortex of both µcalpain and mcalpain, as did siRNA targeting Capns1 (Supplementary  Fig. 6 ). In postnatal day 4 (P4) Lis1 +/+ mice in which neurons in the ventricular zone had been transfected with a plasmid encoding GFP, many labeled cells in the ventricular zone migrated out toward the pial surface (Fig. 4f) . By contrast, neurons in P4 Lis1 +/− mice showed defective placement, consistent with decreased motility (Fig. 4f) . Inactivation of µcalpain and mcalpain partially res cued defective neuronal migration, resulting in a larger fraction of neurons that reached more superficial layers (Fig. 4f) . These data are consistent with our histological examinations and support the hypothesis that calpain inhibition in Lis1 +/− embryos is effective in facilitating neuronal migration.
ALLN partially rescues impaired motor behavior
Lis1 +/− mice show abnormal behavior and are impaired in spatial learning, including hindpaw clutching responses, a rotarod test and the Morris water maze task 29 . Therefore, we examined whether admin istration of ALLN in utero during embryonic development of Lis1 +/− mice (ALLNplus group) is effective in improving motor behavior com pared to untreated Lis1 +/− mice (ALLNminus group). Standard meas urements were not significantly different between the ALLNminus and ALLNplus groups, including body weight and body tempera ture (Supplementary Table 1) . Untreated Lis1 +/+ mice, the ALLN minus group and the ALLNplus group showed similar grip strength (Fig. 5a) . Notably, despite similar grip strength between the ALLN minus group and the ALLNplus group, the ALLNplus group hung on the wire for a longer time before falling (Supplementary Fig. 7 and Fig. 5a ), suggesting that motor coordination in the ALLNplus group was improved. Next, we examined rotarod performance. The time that Lis1 +/+ mice and the ALLNplus group maintained their balance on the top of the rotating rod increased considerably over the six trials (Fig. 5b) . However, the delay before falling for the ALLNminus group was significantly shorter than that recorded for wildtype mice, as we previously reported 29 (Fig. 5b) . Of note, performance on the rotarod test was considerably improved in the ALLNplus group compared to the ALLNminus group (Fig. 5b) . Finally, we analyzed gait dynamics to address quantitative neurological traits of Lis1 +/− mice. Stride length var iability of forelimbs was increased in the ALLNminus group compared to Lis1 +/+ mice (Fig. 5c) 30 . In the ALLNplus group, this variability was improved (Fig. 5c) . Normal paw angles are ~5° in fore paws and ~10° in hind paws. More open angles of the hind paws are associated with ataxia, spinal cord injury and demeyelinating diseases 31 . The ALLNminus group showed a more open angle of the fore paws compared to the Lis1 +/+ group, an abnormality that was rescued in the ALLNplus group (Fig. 5d) . Notably, these aberrant gait parameters were more conspicu ous in the fore paws than in the hind paws. Restoration of normal parameters in gait analysis also supports the conclusion that ALLN injection results in functional improvement of Lis1 +/− mice.
DISCUSSION
In this report, we have presented proof of principle for a potentially effective therapeutic strategy for human lissencephaly, using Lis1 deficient mice that are a model of this disorder. Therapeutic strate gies for lissencephaly are daunting for a number of reasons. First, given the nature of lissencephaly, one would have to treat all neurons throughout development. Second, LIS1 mutations in humans are de novo, so that detection of the disorder at an early enough time point to allow effective therapy is difficult. In spite of these difficulties, there are some aspects of the lissencephaly resulting from LIS1 haploinsuf ficiency that can be advantageous when considering treatment. First, LIS1 protein is present and can potentially be manipulated, as these individuals have heterozygous, not complete, loss of LIS1. Second, there are dosagedependent effects of LIS1, so any augmentation of LIS1 protein abundance is likely to have a beneficial effect. Third, a great deal is known about the pathogenesis and mechanism of action of LIS1 and its pathway, so the effects of any therapeutic modality can be assessed directly with quantitative measures in vivo and in vitro.
We based our therapeutic strategy on our recent observations that LIS1 is degraded after anterograde transport to the nerve terminals in a calpaindependent fashion. Here we found that inhibition of calpain a r t i c l e s resulted in augmentation of LIS1 protein abundance, which led to the rescue of aberrant distribution of cytoplasmic dynein in cells from Lis1 deficient mice. We further showed that inhibition of calpain rescued of granule neurons from these mice, migration. Most notably, we showed that daily ALLN administration in utero was partially effective in rescu ing defective migration phenotypes in vivo in Lis1deficient mice, which was associated with improvement in motor function. Recently, it was shown that increased LIS1 expression affects human and mouse brain development 32 . In our study, inhibition of calpain activity resulted in normalization of LIS1 abundance to close to wild type levels rather than accumulation in excess. We believe that the res toration of close to normal LIS1 abundance is one reason that calpain inhibition resulted in phenotypic improvement of Lis1 +/− mice. We cannot rule out the possibility that other effects of calpain may also have some roles in the observed phenotypic rescue, including suppression of the degradation of spectrin, neurofilaments and microtubules, sup pression of the cleavage of p35, a Cdk5 activator important for neuronal migration [33] [34] [35] , or prevention of the degradation of the other proteins in the LIS1NDEL1dynein complex and/or acetylated tubulin or FAK com plexes 18, 20 , all of which will be the subjects of further investigation.
Several problems remain and must be overcome if this promising avenue of therapy can be eventually tested in human lissencephaly, including further refinement of the use of calpain inhibitors for the effective inhibition of LIS1 degradation as well as the safe and effective delivery of such drugs. In spite of these challenges, our work provides a potential avenue to consider for therapeutic strategies for severe, early brain developmental defects such as lissencephaly due to LIS1 mutations, as well as other disorders that result from haploinsufficiency.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
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Cell culture experiments. We dissociated DRGs from postnatal 129sv and C57/BL6 mice (generated in our mouse facility by mating) using a previously described method 37 . We isolated cerebellar granule cells as described previ ously 9, 10, 12 and cultured them at 1 × 10 6 cells per ml for 12 h, resulting in uni formsized reaggregates (100-150 µm in diameter), which we then transferred to polyLlysine-(SigmaAldrich) and laminin (SigmaAldrich) treated slides and incubated for 8 h. Then we added 10 µM ALLN (Calbiochem), 20 µM E64d (Calbiochem) or control DMSO and further incubated the cultures for 16 h. We obtained images with a 20× objective lens and analyzed images with a confocal microscope (TCSSP5, Leica). Mouse studies were approved by the Animal Research Committee at Osaka City University.
Bromodeoxyuridine birthdating study. For BrdU experiments, we injected pregnant dams (E15.5) with BrdU (50 µg per g body weight, intraperitoneally). Subsequently, we determined the distribution of BrdUpositive cells at P5. For pulse labeling to trace proliferation of neuroepithelial stem cells, we injected pregnant dams (E13.5) with BrdU (150 µg per g body weight, intraperitoneally). Subsequently, we determined the distribution of BrdUpositive cells 1 h after the injection. We detected the incorporation of BrdU in cells using a mouse BrdUspecific monoclonal primary antibody (Roche, 1299964) followed by an alkaline phosphatase-conjugated secondary antibody (Boehringer Mannheim), which we detected with the Vectastain ABC kit (Vector Laboratories PK6200). We analyzed three independent mice for each genotype.
Histological examination and immunohistochemistry. After perfusion with 4% paraformadehyde fixative, we subsequently embedded tissues from wildtype and various mutant mice (generated in our mouse facility by mating) in paraf fin and sectioned them at 5µm thickness. After deparaffination, we blocked endogenous peroxidase activity by incubating the sections in 1.5% peroxide in methanol for 20 min. We then boiled the sections boiled in 0.01 M citrate buffer, pH 6.0, for 20 min and cooled them slowly. Before staining, we blocked the sec tions with rodent block (LabVision) for 60 min. We washed the sections in PBS and incubated them with a Brn1-specific antibody (Santa Cruz, sc6028).
Cell culture and immunocytochemistry. We established MEF cells as previ ously described 9, 12 . We grew MEF cells in DMEM supplemented with 10% FBS. To inhibit calpain, we incubated MEF cells with 10 µM ALLN (Calbiochem), 20 µM E64d (Calbiochem) or control DMSO for 2 h. We fixed the cells in 4% paraformaldehyde in PBS followed by permealization with 0.2% Triton X100 in PBS. We blocked coverslips for 1 h with Block Ace (Yukijirushi) in PBS supplemented with 5% BSA and incubated them for 1 h in primary anti body, washed them, and then incubated them for 1 h with Alexa 546-conju gated secondary antibodies (Molecular Probes). Primary antibodies were a βCOP-specific antibody (Sigma) and a DIC1specific antibody (Chemicon). We stained mitochondria with MitoTracker Green FM (Molecular Probes). The calpainspecific antibody (1D10A7), which recognizes conventional calpain 36 , was provided by S. Kawashima.
Small interfering RNA, short hairpin RNA and transfection. We purchased siRNA and shRNA to target the mouse Capns1 from Sigma (MISSION siRNA: SASI_Mm01_00127701, and MISSION TRC shRNA: TRCN0000087168). We transfected siRNA with Lipofectamine RNAi MAX reagents (Invitrogen). We introduced shRNA by an in utero electroporationmediated gene transfer method 38, 39 . We dissolved shRNA plasmid and pCAGGSGFP control plasmid in HBS (21 mM HEPES, pH 7.0, 137 mM NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 and 1 mg l −1 glucose) at a final concentration of 10 mg ml −1 together with Fast Green (Fisher Scientific; final concentration 0.01%). For cotransfection, we used a molar ratio of 1 (pCAGGSGFP) to 3-6 (shRNA).
Behavioral analysis. We used 41 wildtype (25 males and 16 females), 14 Lis1 +/− (five males and nine females) and 5 Lis1 +/− (12 males and three females) mice that were treated in utero with ALLN for behavioral experiments. Lis1 +/− mice (generated in our mouse facility) had a single Lis1mutant allele. In this study mice were from a mixed genetic background (129SvEv × FVB). All mouse experiments were carried out under protocols approved by the Animal Research Committee of Kyoto University. In this screen, we recorded several physical fea tures and several motor responses of the mice, including body weight and core temperature. We conducted the rotarod test as previously described 40 .
We used 18 (11 males and seven females) wildtype, 13 Lis1 +/− (four males and nine females) mice and 15 Lis1 +/− (12 males and three females) mice that were given ALLN for regular behavioral experiments. We analyzed gait analysis by ventral plane videography as described 41 . Briefly, we placed the mice on a treadmill belt that moves at a speed of 24.7 cm s −1 . We collected digital video images of the underside of mice at 150 frames per second. The paw area indicates the temporal placement of the paw relative to the treadmill belt. We converted the color images to their binary matrix equivalents, and we calculated the areas (in pixels) of the approaching or retreating paws relative to the belt and camera throughout each stride. Plotting the area of each digital paw print (paw contact area) imaged sequentially in time provides a dynamic gait signal, representing the temporal record of paw placement relative to the treadmill belt.
Statistical analyses.
Statistical analysis for behavior analysis was conducted with Stat View (SAS institute). We analyzed data by twoway analysis of variance. Other statistical analysises were performed by the unpaired Student's t test.
